Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 1099-1103, June 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lepage, R.
Right arrow Articles by Morris, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lepage, R.
Right arrow Articles by Morris, H. P.

The Enzymology of the Formation and Interconversion of Labile 1-Carbon Groups in Five Hepatomas and in Walker Tumor 2561

Raymond Lepage, Lionel A. Poirier2, Miriam C. Poirier2 and Harold P. Morris

Institut du Cancer de Montréal, Hôpital Notre-Dame, and Département de Biochimie, Université de Montréal, Montréal, Québec, Canada [R. L., L. A. P., M. C. P.], and Department of Biochemistry, Howard University, Washington, D. C. 20001 [H. P. M.]

The levels of the enzymes histidase, urocanase, formiminoglutamic acid transferase, dihydrofolate reductase, serine hydroxymethylase, N5,10-methylenetetrahydrofolate dehydrogenase, and formylase, all involved in the metabolism of 1-carbon and related compounds, were determined in the cytoplasmic fractions of 5 rat hepatomas, Walker tumor 256, and livers of tumor-bearing rats. The hepatomas studied included the Novikoff, H-35, and Morris 7800, 7777, and 5123D hepatomas. The activities of virtually all enzymes studied were significantly decreased in hepatomas in comparison to corresponding activities in livers of tumor-bearing rats. The hepatoma levels of formiminoglutamic acid transferase and serine hydroxymethylase never exceeded 7 and 41%, respectively, the corresponding enzyme levels found in host liver. The levels of histidase, urocanase, and dihydrofolate reductase were also significantly lower in all hepatomas studied than in livers of tumor-bearing rats. The levels of formylase in the 5123D hepatoma and of N5,10-methylenetetrahydrofolate dehydrogenase in hepatoma H-35 were found to be comparable to the corresponding enzyme level in livers of tumor-bearing rats; in all other hepatomas studied, however, the levels of these two enzymes were lower than in the host livers. With the exception of serine hydroxymethylase, the activities of all enzymes studied were similar in the two rapidly growing tumors, the Novikoff hepatoma and Walker carcinosarcoma 256. No other correlations could be observed between the growth rates of tumors studied and the levels of any enzymes investigated. The results are consistent with an overall decrease in both the 1-carbon and tetrahydrofolate moieties of the labile 1-carbon pool of tumors and with a decreased interconversion of the metabolically labile formyl and hydroxymethyl groups.

1 This research was supported by grants from the National Cancer Institute of Canada, The Conseil de la Recherche Médicale du Québec, and USPHS Grant CA 10729.

2 Present address: National Cancer Institute, NIH, Bethesda, Md. 20014.

Received 6/10/71. Accepted 2/18/72.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.